secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001104659-25-089150
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Armata presents at H.C. Wainwright conference; no new data in exhibit
---------------------------------------------------------------------

- CEO Dr. Deborah Birx presented at H.C. Wainwright 27th Annual Global Investment Conference on Sept 10, 2025.
- Exhibit 99.1 contains only title slide and forward-looking disclaimers; no new clinical or financial data.
- Prior $26.2M DoD award referenced in disclaimers; no update on program milestones or guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465925089150/0001104659-25-089150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465925089150/tm2525814d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-089150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer